Skip to content
Breaking
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Welcoming Three New Leaders to the CureSearch Board of Directors
A Pan-Canadian Team Develops Revolutionary Egg-Based Tumor Model for Rapid, Personalized Cancer Treatment Discovery
Estrogen Hormone Regulates Female Binge Drinking, Driving Rapid Alcohol Consumption and Contributing to Sex Differences in Behavior
Routine Calcium and Vitamin D Supplementation Offers Little Benefit Against Falls and Fractures for Most Older Adults, Major Review Concludes
The Dual Nature of a Crucial Enzyme: PI3K Possesses Both Accelerator and Brake for Cell Migration
Genetically Tailored Treatment Plans for Children with Wilms Tumour Promise More Effective Care and Minimized Side Effects
21 Sep 2026, Mon
Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Sep 21, 2026
Breaking Oncology News & General Research

Deciphering T Cell Fate: New Genetic Mechanisms Unveiled to Reverse Exhaustion and Enhance Cancer Immunotherapy.

Budi Oetomo Narendra Mar 7, 2026

Researchers from the Salk Institute for Biological Studies, UNC Lineberger Comprehensive Cancer Center, and UC...

Breaking Oncology News & General Research

Dr. Vinay Prasad, Controversial Head of FDA’s Vaccines and Biologics Division, Confirmed to Depart Agency Amidst Scrutiny

admin Mar 7, 2026

Dr. Vinay Prasad, a figure known for his outspoken critical analyses within the medical community...

Breaking Oncology News & General Research

Vinay Prasad, Architect of Controversial Regulatory Shifts and Figure in FDA Leadership Turnover, Exits Agency for Second Time

admin Mar 7, 2026

WASHINGTON – Vinay Prasad, a prominent official at the Food and Drug Administration (FDA) whose...

Biotech, Pharma & Cancer Drug Development

Alnylam Forges Landmark $1.23 Billion Cardiovascular Discovery Alliance with Tenaya Therapeutics to Advance Disease-Modifying Therapies

admin Mar 6, 2026

Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...

Genitourinary, Prostate & Kidney Cancer

Veterans Find New Hope and Longevity Through Advanced Prostate Cancer Clinical Trials at Washington DC VA Medical Center

admin Mar 6, 2026

The landscape of oncological care within the Department of Veterans Affairs (VA) is undergoing a...

Gastrointestinal & Colorectal Cancers

Understanding Colorectal Cancer: A Comprehensive Guide to Facts, Risks, Symptoms, and Screening

admin Mar 6, 2026

Colorectal cancer, a formidable disease affecting the colon or rectum, is a growing public health...

Gastrointestinal & Colorectal Cancers

Pancreatic Cancer Action Network Reaffirms Commitment to Advancing Research and Patient Support Through Trademark Protections

admin Mar 6, 2026

The Pancreatic Cancer Action Network (PanCAN) has reaffirmed its dedication to advancing critical research and...

Breast Cancer: Research & Awareness

A Paradigm Shift in Colorectal Cancer Immunotherapy: Sloan Kettering Institute Uncovers Dual Role of Regulatory T Cells

admin Mar 6, 2026

For decades, the scientific community has grappled with a perplexing paradox in colorectal cancer (CRC)...

Breaking Oncology News & General Research

AI blood test finds silent liver disease years before symptoms

Budi Oetomo Narendra Mar 6, 2026

A groundbreaking advancement in medical diagnostics has emerged from the Johns Hopkins Kimmel Cancer Center,...

Biotech, Pharma & Cancer Drug Development

FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo

admin Mar 6, 2026

The pharmaceutical landscape for multiple myeloma has witnessed a significant acceleration with the U.S. Food...

Posts pagination

1 … 364 365

Posts Carousel

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Trending
Popular
Latest
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026

You Missed

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

Copyright © All rights reserved | Newspaperup by Themeansar.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.